Terms: = Prostate cancer AND PTPN13, PTP1E, 5783, ENSG00000163629, PTPLE, PTPL1, PNP1, PTP-BAS, DKFZp686J1497, Q12923, FAP-1, PTP-BL
17 results:
1. Recruiting African American prostate cancer Survivors for a Population-based Biobank Study.
Li X; Roy S; Damonte J; Park HY; Hoogland AI; Jamison K; Komrokji KR; Yeo CD; Kim Y; Dhillon J; Gudenkauf LM; Oswald LB; Jim HSL; Yamoah K; Pow-Sang JM; Kanetsky PA; Gwede CK; Park JY; Gonzalez BD
Cancer Epidemiol Biomarkers Prev; 2023 Jun; 32(6):768-775. PubMed ID: 36958853
[TBL] [Abstract] [Full Text] [Related]
2. Administration Routes for SSTR-/PSMA- and FAP-Directed Theranostic Radioligands in Mice.
Klose JM; Wosniack J; Iking J; Staniszewska M; Zarrad F; Trajkovic-Arsic M; Herrmann K; Costa PF; Lueckerath K; Fendler WP
J Nucl Med; 2022 Sep; 63(9):1357-1363. PubMed ID: 34992151
[TBL] [Abstract] [Full Text] [Related]
3. Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the prostate for Very High-Risk Adenocarcinoma of the prostate: A Prospective Phase II Clinical Trial.
Hall WA; Bedi M; Kilari D; Bylow KA; Burfeind J; Johnstone C; Siker M; Currey A; See WA; Nelson A; Johnson S; Straza M; Lawton CAF
Pract Radiat Oncol; 2021; 11(6):527-533. PubMed ID: 33848618
[TBL] [Abstract] [Full Text] [Related]
4. Human papillomavirus and prostate cancer: The role of viral expressed proteins in the inhibition of anoikis and induction of metastasis.
Fatemipour M; Nahand JS; Fard Azar ME; Baghi HB; Taghizadieh M; Sorayyayi S; Hussen BM; Mirzaei H; Moghoofei M; Bokharaei-Salim F
Microb Pathog; 2021 Mar; 152():104576. PubMed ID: 33086103
[TBL] [Abstract] [Full Text] [Related]
5. In-Bore Transrectal MRI-Guided Biopsy With Robotic Assistance in the Diagnosis of prostate cancer: An Analysis of 57 Patients.
Barral M; Lefevre A; Camparo P; Hoogenboom M; Pierre T; Soyer P; Cornud F
AJR Am J Roentgenol; 2019 Oct; 213(4):W171-W179. PubMed ID: 31268734
[No Abstract] [Full Text] [Related]
6. Three-month posttreatment prostate-specific antigen level as a biomarker of treatment response in patients with intermediate-risk or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapy.
Bryant AK; D'Amico AV; Nguyen PL; Einck JP; Kane CJ; McKay RR; Simpson DR; Mundt AJ; Murphy JD; Rose BS
Cancer; 2018 Jul; 124(14):2939-2947. PubMed ID: 29727915
[TBL] [Abstract] [Full Text] [Related]
7. Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells.
Bowler E; Porazinski S; Uzor S; Thibault P; Durand M; Lapointe E; Rouschop KMA; Hancock J; Wilson I; Ladomery M
BMC Cancer; 2018 Apr; 18(1):355. PubMed ID: 29606096
[TBL] [Abstract] [Full Text] [Related]
8. High Incidence of Incidental prostate cancer in Transurethral Resection of prostate Specimens in China. The Value of Pathologic Review.
Lin J; Yu X; Yang X; Jin J; Zhou L; Liu L; Su J; Li Y; Shang M
Anal Quant Cytopathol Histpathol; 2016 Feb; 38(1):31-7. PubMed ID: 27363064
[TBL] [Abstract] [Full Text] [Related]
9. Sildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95.
Das A; Durrant D; Mitchell C; Dent P; Batra SK; Kukreja RC
Oncotarget; 2016 Jan; 7(4):4399-413. PubMed ID: 26716643
[TBL] [Abstract] [Full Text] [Related]
10. ptpl1 and PKCδ contribute to proapoptotic signalling in prostate cancer cells.
Castilla C; Chinchón D; Medina R; Torrubia FJ; Japón MA; Sáez C
Cell Death Dis; 2013 Apr; 4(4):e576. PubMed ID: 23559010
[TBL] [Abstract] [Full Text] [Related]
11. Downregulation of protein tyrosine phosphatase ptpl1 alters cell cycle and upregulates invasion-related genes in prostate cancer cells.
Castilla C; Flores ML; Conde JM; Medina R; Torrubia FJ; Japón MA; Sáez C
Clin Exp Metastasis; 2012 Apr; 29(4):349-58. PubMed ID: 22274591
[TBL] [Abstract] [Full Text] [Related]
12. The role of PCA3 testing in patients with a raised prostate-specific antigen level after Greenlight photoselective vaporization of the prostate.
Henderson J; Ghani KR; Cook J; Fahey M; Schalken J; Thilagarajah R
J Endourol; 2010 Nov; 24(11):1821-4. PubMed ID: 20964483
[TBL] [Abstract] [Full Text] [Related]
13. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143.
Li Y; Raffo AJ; Drew L; Mao Y; Tran A; Petrylak DP; Fine RL
Cancer Res; 2003 Apr; 63(7):1527-33. PubMed ID: 12670900
[TBL] [Abstract] [Full Text] [Related]
14. Immunohistochemical localization of fap-1, an inhibitor of Fas-mediated apoptosis, in normal and neoplastic human tissues.
Lee SH; Shin MS; Park WS; Kim SY; Kim HS; Lee JH; Han SY; Lee HK; Park JY; Oh RR; Jang JJ; Lee JY; Yoo NJ
APMIS; 1999 Dec; 107(12):1101-8. PubMed ID: 10660140
[TBL] [Abstract] [Full Text] [Related]
15. Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage.
Hedlund TE; Duke RC; Schleicher MS; Miller GJ
Prostate; 1998 Jul; 36(2):92-101. PubMed ID: 9655261
[TBL] [Abstract] [Full Text] [Related]
16. Prevalence and impact of incontinence and impotence following total prostatectomy assessed anonymously by the ICS-male questionnaire.
Bates TS; Wright MP; Gillatt DA
Eur Urol; 1998; 33(2):165-9. PubMed ID: 9519358
[TBL] [Abstract] [Full Text] [Related]
17. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
[TBL] [Abstract] [Full Text] [Related]
